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ABSTRACT 
Introduction: Left ventricular non-compaction cardiomyopathy (LVNC) is a rare 
cardiomyopathy, originally described as an isolated disease without other structural 
cardiac abnormalities. The aim of this study was to explore the prevalence of LVNC 
among adults with different types of congenital heart disease. 
Methods: From our databases we identified adults with congenital heart disease who 
fulfilled diagnostic criteria for LVNC. We report frequencies of associated congenital 
cardiac defects and the prevalence of LVNC among patients with different congenital 
heart defects.  
Results: From a total of 202 patients with LVNC, 24 patients (12%; mean age 32±11 
years, 7 females, 17 males) had additional congenital cardiac defects. Associated 
defects were left ventricular outflow tract abnormalities in 11 patients (46%), including 
7 uni- or bicuspid aortic valves; two aortic coarctations; one diffuse aortic hypoplasia 
and one subaortic stenosis, Ebstein anomaly in 6 patients (25%), tetralogy of Fallot in 
two (8%), and double outlet right ventricle in one patient (4%). In our cohort, the 
prevalence of LVNC was highest among patients with Ebstein anomaly (6/40, 15%), 
followed by aortic coarctation (2/60, 3%), tetralogy of Fallot (3/129, 2%) and uni- or 
bicuspid aortic valves (7/963, 1%).  
Conclusion: In adults, various forms of congenital heart disease are associated with 
LVNC, particularly stenotic lesions of the left ventricular outflow tract, Ebstein 
anomaly, and tetralogy of Fallot. In the future, studying these patients in more depth 
may provide a better understanding of the interplay between genetic and 
hemodynamic factors that lead to the phenotype of LVNC. 
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INTRODUCTION 
Since its first description, left ventricular non-compaction (LVNC) 
cardiomyopathy has gained increasing awareness and attention. 1-3 By its original 
definition4, the absence of other structural heart disease is a prerequisite for the 
diagnosis of LVNC cardiomyopathy. The clinical presentation and outcome of 
patients with isolated LVNC is variable. Symptomatic patients have an adverse long-
term outcome, while outcome in asymptomatic patients seems to be more 
favourable. 5-15 Typical complications include congestive heart failure, ventricular 
arrhythmias and thromboembolic events.12-14,16,17 
Recently, the association of LVNC with metabolic diseases, genetic 
syndromes and other cardiac abnormalities has been reported. 18-20 Genetic studies 
have shown sarcomere gene mutations in some patients with isolated LVNC similar 
to those with dilated or hypertrophic cardiomyopathy, and a recent study has found 
similar mutations in patients with Ebstein anomaly. 21,22 There is, however, no clear 
genotype–phenotype association. 23 Genetic abnormalities may thus cause both 
structural congenital malformations and impaired left ventricular myocardial 
differentiation. Alternatively, hemodynamic alterations during fetal life may be a co-
factor for the development of ventricular non-compaction in a patient with genetic 
predisposition. 24,25 
The purpose of this study was to explore the association between congenital 
heart defects and LVNC and to report its prevalence within adults with a distinct type 
of congenital cardiac defect. 
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METHODS 
 
Patients 
From January 1987 to November 2011 all patient, who fulfilled diagnostic 
criteria for LVNC were identified from our clinical echocardiographic database. While 
there are no generally accepted diagnostic criteria for LVNC, for the purpose of this 
study, we used echocardiographic criteria as proposed by our group.4,5 These criteria 
have been shown to identify a subset of symptomatic patients at risk for adverse 
outcome. 15 In brief, the criteria include a combination of 1) segmental thickening of 
the left ventricular myocardial wall 2) consisting of an inner non-compacted and an 
outer compacted layer with 3) a thickness ratio ≥ 2:1 at end-systole, measured in the 
parasternal short-axis view, and 4) presence of deep recesses with evidence of blood 
flow from the ventricular cavity by color Doppler.  No other imaging modality was 
used for diagnosis in this study. Patients identified with LVNC were cross-linked with 
our congenital cardiac database to identify subjects with both, congenital heart 
disease and LVNC and to determine the frequency of LVNC among patients with 
individual congenital cardiac disease entities.  
Baseline characteristics included demographic characteristics at last follow-up, 
exact anatomical cardiac diagnoses, previous surgical and non-surgical treatment 
history, previous cardiovascular complications and left ventricular function at last 
follow-up.  
This manuscript also complies with the Principles of Ethical Publishing in the 
International Journal of Cardiology.26 
 
Echocardiography 
Transthoracic two-dimensional echocardiography was performed using 
commercially available equipment. Left and right ventricular dimensions and function 
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were assessed according to established guidelines for two-dimensional 
echocardiography. 27  
 
Statistical analysis 
Continuous variables are presented as mean ± standard deviation, and 
medians and ranges as appropriate. Categorical variables are given as frequencies 
and percentages. All statistical analyses were performed with the use of SAS version 
9.1 (SAS Institute Inc, Cary, NC). 
 
 
 
RESULTS 
Patients 
We identified a total of 202 patients with LVNC, of whom 24 (12%) had associated 
congenital cardiac defects. These 24 patients comprised the study group. All study 
patients were diagnosed with LVNC at their first visit in the adult clinic. We did not 
observe patients who fulfilled diagnostic criteria during follow-up only. Nineteen 
(79%) were males and median age at last follow-up was 31 years (range 24-44). Two 
patients (8%) had a family history of LVNC. None of the patients in this cohort had a 
known syndromic association.  Table 1 illustrates types of congenital cardiac defects, 
previous surgical procedures and data about left ventricular dimensions and systolic 
function at last follow-up.  
As illustrated in figure 1A the most common associated congenital cardiac 
defects were different forms of left ventricular outflow tract abnormalities and/or 
obstruction (11/24, 46%), including 7 patients with uni- or bicuspid aortic valves; 2 
patients with aortic coarctation 1 patient with diffuse hypoplasia of the aorta and 1 
patient with subaortic stenosis. The second largest group were patients with Ebstein 
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anomaly of the tricuspid valve (6/24, 25%), followed by patients with tetralogy of 
Fallot or double outlet right ventricle of Fallot-type (3/24, 13%). Typical case 
examples of patients with these three congenital cardiac disease entities are 
illustrated in figures 2-4. 
 
Previous cardiovascular complications 
 
Twenty-three patients (96%) were in sinus rhythm and 1 patient (4%) was in 
permanent atrial fibrillation. One patient (4%) suffered a stroke at age 39 years, of 
potentially cardioembolic cause (patient 15). Seven patients (29%) had a history of 
supraventricular tachycardia. These included 4 patients with atrial flutter or fibrillation 
and 3 patients with Ebstein-anomaly and concomitant Wolff-Parkinson-White 
syndrome with associated AV- reentrant tachycardia). Two patients had a history of 
sustained ventricular tachycardia (one patient with tricuspid valve dysplasia in the 
setting of severe tricuspid regurgitation and 1 patient with Ebstein-anomaly of the 
tricuspid valve). One patient with poor left ventricular ejection fraction (patient 19 in 
table 1) was treated for symptomatic congestive heart failure. 
 
Echocardiographic features 
 Mean left ventricular ejection fraction was 52±9% (range 24-61%). 9 patients 
(37%) had a left ventricular ejection fraction <52% and 3 patients (13%) had dilated 
left ventricles. Left ventricular diastolic dysfunction was detected in 4 patients (17%). 
Left ventricular segments most commonly involved were apical (23/24, 96%) 
midventricular inferior (9/24, 38%) and midventricular lateral (9/24, 38%). In 1 patient 
(table 1 – patient 22, figure 4) markedly abnormal right ventricular myocardium was 
noted, suggesting right ventricular involvement. 
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Prevalence of left ventricular non-compaction among different congenital 
cardiac defects 
As illustrated in figure 1B, the prevalence of LVNC in patients with a distinct 
congenital heart defect was significantly different between different congenital 
cardiac lesions. The prevalence of patients with concomitant LVNC was highest 
among patients with Ebstein anomaly (6/40, 15%), followed by aortic coarctation 
(2/60, 3%), tetralogy of Fallot (3/129, 2%) and uni- or bicuspid aortic valves (7/963, 
1%) (p < 0.001 for comparison between groups).  
 
 
 
DISCUSSION 
In this study of adults with congenital heart disease we report types of 
congenital cardiac defects most commonly associated with LVNC and report 
prevalence of LVNC among these congenital cardiac disease entities. The most 
common congenital cardiac defects associated with LVNC were various forms of left 
ventricular outflow tract abnormalities and obstructions, Ebstein anomaly and 
tetralogy of Fallot. The prevalence of LVNC was highest for Ebstein anomaly followed 
by aortic coarctation, tetralogy of Fallot, and bicuspid aortic valves. 
Recently, it has been shown in a pediatric series that left ventricular non-
compaction with associated congenital heart disease confers additional risk. 28  While 
our study is too small to assess the effect of LVNC on cardiac outcomes in patients 
with congenital heart disease, our observations raise a number of hypotheses 
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regarding the development of LVNC in patients with and without concomitant 
congenital heart lesions.  
Ebstein anomaly is thought to be caused by failure of right heart differentiation 
in such that the tricuspid valve leaflets do not delaminate properly from the 
myocardial mass during embryologic development. The association of Ebstein 
anomaly and LVNC has been reported. 29 A recent study has found similar 
sarcomeric gene mutations in patients with Ebstein anomaly and in patients with 
isolated forms of LVNC. 22 This suggests that a similar genetic predisposition may 
lead to both, defective right and left ventricular myocardial differentiation with different 
morphologic-phenotypic manifestations. Comparable mechanisms may play a role in 
patients with conotruncal defects in whom the outflow tract of both, the right and left 
ventricle, and thus differentiation of right and left ventricular myocardial mass may be 
abnormal. 
On the other hand, LVNC in the setting of congenital left ventricular outflow 
tract obstruction may be a model for the interplay between hemodynamic factors that 
trigger abnormal left ventricular differentiation in a genetically susceptible individual. 
Indeed, the variability of hereditary patterns in LVNC raise the question whether 
LVNC reflects a primary abnormality in the early myocardial morphogenesis or 
develops pre- or even postnatal due to additional triggers and modifiers, such as 
pressure overload on the developing left ventricle due to outflow tract obstruction. 
Better characterization of genetic mutations and phenotypic abnormalities in 
left ventricular development in patients with LVNC and congenital heart disease may 
therefore have an important role for a better understanding of pathophysiology and 
development of LVNC in patients without associated congenital heart disease. 
Whether LVNC in association with other pathologies has a similar or different genetic 
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basis, pathobiology, and natural course, and whether different mechanisms account 
for different entities of LVNC remains a matter of further research. 
As there may be a genetic susceptibility for abnormal myocardial development 
in patients with LVNC in the setting of congenital heart defects, it may be wise to offer 
family screening to relatives of these patients in order to identify yet asymptomatic 
patients with LVNC that may be at risk for future deterioration.16  
As in all series of patients with LVNC the absence of generally accepted 
diagnostic criteria for this disease entity remains a dilemma. While the criteria 
proposed by our group may be too sensitive, particularly in black individuals, they 
may identify symptomatic patients of a Caucasian population at high risk for 
cardiovascular complications. 
The hypotheses raised in the discussion section of this paper remain 
unproven, as formal genetic testing is missing in this and other patient cohort. Further 
studies will be needed to validate these issues. 
In patients with LVNC and left ventricular outflow tract obstructions, LVNC 
must be differentiated from persisting myocardial sinusoids with connection to the 
coronary circulation, a well-known abnormality of coronary artery differentiation in 
patients with high endoventricular pressures during embryological development. 
Although there was no evidence of such sinusoids with connection to the coronary 
arteries in any of the patients included into this cohort, not all patients had undergone 
selective coronary angiography or angiograms were not available for review. 
The number of affected patients within this series is small. Thus, to determine 
the impact of the additional presence of LVNC on cardiovascular outcomes in 
affected patients with congenital heart disease, larger cohorts with long-term follow-
up are needed. Ideally, these patients should be followed in a multicenter registry to 
further evaluate characteristics and outcomes of LVNC in the setting of different 
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forms of congenital heart disease and to assess the impact of LVNC on 
cardiovascular outcomes in patients with congenital heart disease. 
In this study we used only echocardiography for the diagnosis of LVNC. In the 
future, other imaging modalities, such as cardiac magnetic resonance imaging or 
computed tomography may be useful for diagnosis of LVNC in patients with 
suboptimal acoustic windows on echocardiography. 
In conclusion, various forms of congenital heart disease may be associated 
with LVNC, particularly stenotic lesions of the left ventricular outflow tract, Ebstein 
anomaly, and tetralogy of Fallot. In the future, studying these patients in more depth 
may provide a better understanding of the interplay between genetic and 
hemodynamic factors that lead to the phenotype of LVNC. 
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Figure Legends 
 
 
Table 1: Anatomical characteristics, previous surgeries and left ventricular 
dimensions and function 
Abbreviations: LVEF: Left ventricular ejection fraction; EDVI: Left ventricular 
enddiastolic volume indexed to body surface area 
 
 
Figure 1: A: Proportional distribution of patients with LVNC and congenital heart 
disease within the study cohort. B: Prevalence of LVNC among the most commonly 
affected congenital cardiac lesions 
 
Figure 2: LVNC in left ventricular outflow tract obstruction. 18-year old patient 
with bicuspid aortic valve, hypoplastic aortic annulus (no systolic pressure gradient in 
LVOT), hypoplastic left ventricle and secundum type atrial septal defect. Panel A 
shows a 4-chamber view on cardiac magnetic resonance imaging depicting the small 
left ventricular cavity with abnormal trabeculations with deep recessi of the left 
ventricular lateral wall. Panel B shows right (green curve) and left (red curve) 
ventricular inflow velocities, recorded on cardiac magnetic resonance imaging, 
illustrating the abnormal filling pattern of the left ventricle. Panel C and D show short 
axis view of the left ventricle on cardiac magnetic resonance imaging (panel C) and 
the corresponding image on echocardiography (panel D). 
 
Figure 3: LVNC in Ebstein anomaly of the tricuspid valve. 40-year old patient with 
Ebstein anomaly and secundum type atrial septal defect. Panel A and B depict 
markedly thickened apikal and lateral left ventricular wall with perfused recessi. Panel 
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C and D show still frames during injection of agitated saline into the right cubital vein 
(panel C before and panel D immediately after appearance of bubble contrast into 
the right atrium). Massive right-to-left shunt without Valsalva-manoeuvre suggests 
high right sided filling pressures. 
 
Figure 4: LVNC in Fallot-type double outlet right ventricle. 27-year old patient 
with repaired double outlet right ventricle of Fallot-type. Panel A shows the apical 4-
chamber view with highly trabeculated left ventricular apex and panel B a parasternal 
short axis view below the level of the papillary muscles with the typically thickened, 
two-layered left ventricular lateral wall. Panel C shows the highly trabeculated right 
ventricle suggesting right ventricular involvement. 
